Sodium (6R,7R)-3-[(4-carbamoyl-1-pyridiniumyl)methyl]-8-oxo-7-{[(2R)-2-phenyl-2-sulfonatoacetyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

Basic Information

View in Editor

CAS Number

52152-93-9

Molecular Formula

C22H19N4NaO8S2

Molecular Weight

554.5 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Amines

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

Melting Point

175 C

Water Solubility

Soluble in water.

Solubility

H2O: 50 mg/mL, clear, light yellow

SMILES

View in Editor

C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)S(=O)(=O)[O-])C(=O)[O-])C[N+]4=CC=C(C=C4)C(=O)N.[Na+]

InChI

InChI=1S/C22H20N4O8S2.Na/c23-18(27)13-6-8-25(9-7-13)10-14-11-35-21-15(20(29)26(21)16(14)22(30)31)24-19(28)17(36(32,33)34)12-4-2-1-3-5-12;/h1-9,15,17,21H,10-11H2,(H4-,23,24,27,28,30,31,32,33,34);/q;+1/p-1/t15-,17-,21-;/m1./s1

InChIKey

REACMANCWHKJSM-DWBVFMGKSA-M

LogP

-0.12670

Complexity

1040

Safety Information

View Safety Information

GHS Hazard Pictograms

H317

Hazard Statement

H317 May cause an allergic skin reaction
Sensitization, Skin

Toxicity

LD50 in mice (mg/kg): >4000 i.p.; >15000 orally (Bryskier)

Synonyms & References

English

CEFSULODIN SODIUM [JAN]
PYRIDINIUM, 4-(AMINOCARBONYL)-1-((2-CARBOXY-8-OXO-7-((PHENYLSULFOACETYL)AMINO)-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-EN-3-YL)METHYL)-, HYDROXIDE, INNER SALT, MONOSODIUM SALT, (6R-(6.ALPHA.,7.BETA.(R*)))
CEFSULODIN SODIUM SALT [MI]
Cefsulodin sodium [USAN:JAN]
52152-93-9
HMS3260D20
Cefsulodin (sodium)
Pyridinium, 4-(aminocarbonyl)-1-(((6R,7R)-2-carboxy-8-oxo-7-(((2R)-phenylsulfoacetyl)amino)-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, monosodium salt
CGP-7174/E
MFCD07793338
Pyocefal
CEFSULODIN SODIUM [USAN]
Cefsulodin sodium salt (SCE-129), Antibiotic for Culture Media Use Only
4-Carbamoyl-1-(((6R,7R)-2-carboxy-8-oxo-7-((2R)-2-phenyl-2-sulfoacetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)pyridinium hydroxide, inner salt, monosodium salt
NCGC00093718-01
CGP-71741E
2D087186PY
CEFSULODIN SODIUM [WHO-DD]
Cefomonil
Abbott 46811
CEFSULODIN SODIUM [MART.]
Cefsulodine sodium
Cefsulodin sodium salt hydrate
NSC 758163
Pyridinium, 4-(aminocarbonyl)-1-((2-carboxy-8-oxo-7-((phenylsulfoacetyl)amino)-5-thio-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, hydroxide, inner salt, monosodium salt, (6R-(6-alpha,7-beta(R*)))-
Sulcephalosporin
Takesulin (TN)
CGP 7174E
Abbott-468 11
NCGC00093718-02
SCE 129

MDL Number

MFCD29472517

FAQ

What regulatory guidelines apply to Sodium (6R,7R)-3-[(4-carbamoyl-1-pyridiniumyl)methyl]-8-oxo-7-{[(2R)-2-phenyl-2-sulfonatoacetyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (CAS: 52152-93-9)?

This compound must adhere to global regulations such as GHS classification for hazardous materials, REACH regulations in the EU, and FDA/EPA requirements for chemical safety in the United States. It is important to follow local and international guidelines for its storage, handling, and disposal.

Are there alternatives to Sodium (6R,7R)-3-[(4-carbamoyl-1-pyridiniumyl)methyl]-8-oxo-7-{[(2R)-2-phenyl-2-sulfonatoacetyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (CAS: 52152-93-9) in synthesis?

Common alternatives in synthesis include other sulfur-containing analogs or isomers, such as N-(4-carbamoyl-1-pyridinium-3-yl)acetamide, which can serve as effective substitutes. These alternatives can offer similar reactivity in various synthetic processes.

What is the market or research trend for Sodium (6R,7R)-3-[(4-carbamoyl-1-pyridiniumyl)methyl]-8-oxo-7-{[(2R)-2-phenyl-2-sulfonatoacetyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (CAS: 52152-93-9)?

The demand for this compound is growing in pharmaceutical and research applications, particularly in the development of new antibacterial agents. Market trends suggest increasing interest in exploring its therapeutic potential and expanding its use in novel drug formulations.

How should waste containing Sodium (6R,7R)-3-[(4-carbamoyl-1-pyridiniumyl)methyl]-8-oxo-7-{[(2R)-2-phenyl-2-sulfonatoacetyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (CAS: 52152-93-9) be handled?

Waste containing this compound should be collected in appropriate containers and stored properly. It should be disposed of through professional waste disposal services that comply with environmental protection regulations. Incineration, if necessary, should be performed in controlled environments to minimize environmental impact.